I think IPIX will partner B-OM based upon their original plans to get indications through Phase 2, but allow others (BPs) who are better equipped to take them to commercialization. I think back to the August non-binding term sheet....which is probably a good indicator of what they intend to do. I also think if they were going it alone with B-OM, they would have indicated as such by now since they have some up-front money from Alfasigma. I could be way off of course and this is all JMHO.